Federated Hermes’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-8,000
Closed -$79.4K 2094
2025
Q3
$79.4K Hold
8,000
﹤0.01% 1608
2025
Q2
$79.4K Hold
8,000
﹤0.01% 1600
2025
Q1
$104K Hold
8,000
﹤0.01% 1582
2024
Q4
$102K Sell
8,000
-5,600,200
-100% -$67.7M ﹤0.01% 1570
2024
Q3
$62.5M Sell
5,608,200
-1,538,569
-22% -$17M 0.14% 195
2024
Q2
$80.3M Sell
7,146,769
-842,005
-11% -$9.8M 0.19% 133
2024
Q1
$99.1M Sell
7,988,774
-3,375,892
-30% -$44M 0.23% 113
2023
Q4
$159M Sell
11,364,666
-1,264,059
-10% -$17.6M 0.39% 52
2023
Q3
$187M Sell
12,628,725
-26,638
-0.2% -$375K 0.5% 40
2023
Q2
$164M Hold
12,655,363
0.41% 48
2023
Q1
$124M Buy
12,655,363
+15,000
+0.1% +$160K 0.31% 62
2022
Q4
$134M Buy
12,640,363
+25,000
+0.2% +$290K 0.37% 52
2022
Q3
$132M Sell
12,615,363
-3,407,368
-21% -$44.4M 0.39% 53
2022
Q2
$202M Sell
16,022,731
-515,107
-3% -$5.47M 0.55% 34
2022
Q1
$179M Buy
16,537,838
+330,000
+2% +$4.01M 0.41% 47
2021
Q4
$228M Buy
16,207,838
+874,438
+6% +$14.4M 0.42% 44
2021
Q3
$295M Buy
15,333,400
+1,089,600
+8% +$14.5M 0.56% 23
2021
Q2
$140M Buy
14,243,800
+1,639,077
+13% +$14.9M 0.26% 95
2021
Q1
$124M Buy
12,604,723
+657,923
+6% +$5.42M 0.24% 114
2020
Q4
$53.2M Buy
11,946,800
+1,000,000
+9% +$4.53M 0.11% 235
2020
Q3
$47.3M Sell
10,946,800
-220,000
-2% -$1.57M 0.11% 219
2020
Q2
$99M Buy
11,166,800
+1,400,000
+14% +$7.08M 0.25% 98
2020
Q1
$34.5M Buy
9,766,800
+520,000
+6% +$2.41M 0.1% 220
2019
Q4
$52.9M Buy
9,246,800
+495,350
+6% +$2.65M 0.12% 205
2019
Q3
$31.3M Buy
8,751,450
+3,910,750
+81% +$15.2M 0.08% 264
2019
Q2
$19.3M Buy
4,840,700
+1,027,300
+27% +$5.96M 0.05% 365
2019
Q1
$27.9M Buy
3,813,400
+151,800
+4% +$1.48M 0.07% 273
2018
Q4
$33.5M Buy
3,661,600
+2,062,348
+129% +$22.8M 0.09% 232
2018
Q3
$19.8M Sell
1,599,252
-58,523
-4% -$792K 0.05% 353
2018
Q2
$25.3M Sell
1,657,775
-764,654
-32% -$13.2M 0.07% 213
2018
Q1
$48.1M Sell
2,422,429
-44,039
-2% -$761K 0.14% 126
2017
Q4
$46.1M Sell
2,466,468
-101,292
-4% -$2.03M 0.13% 136
2017
Q3
$55.2M Sell
2,567,760
-920,112
-26% -$14.6M 0.16% 116
2017
Q2
$33.7M Sell
3,487,872
-255,279
-7% -$1.66M 0.1% 180
2017
Q1
$22.3M Buy
3,743,151
+123,978
+3% +$596K 0.06% 265
2016
Q4
$14.3M Buy
3,619,173
+659,373
+22% +$4.83M 0.04% 341
2016
Q3
$31M Hold
2,959,800
0.09% 181
2016
Q2
$43.2M Sell
2,959,800
-245,500
-8% -$4.2M 0.13% 132
2016
Q1
$61.7M Buy
3,205,300
+227,671
+8% +$4.6M 0.19% 94
2015
Q4
$71.9M Buy
2,977,629
+1,510
+0.1% +$37.8K 0.23% 87
2015
Q3
$73M Buy
2,976,119
+102,460
+4% +$2.9M 0.24% 77
2015
Q2
$67.3M Sell
2,873,659
-391,941
-12% -$8.54M 0.2% 98
2015
Q1
$73.2M Sell
3,265,600
-145,900
-4% -$2.8M 0.22% 93
2014
Q4
$57.5M Hold
3,411,500
0.18% 106
2014
Q3
$48.8M Hold
3,411,500
0.16% 122
2014
Q2
$54.6M Sell
3,411,500
-59,000
-2% -$890K 0.17% 116
2014
Q1
$62.5M Sell
3,470,500
-53,431
-2% -$991K 0.21% 100
2013
Q4
$69.1M Buy
3,523,931
+922,414
+35% +$13.5M 0.24% 85
2013
Q3
$31.2M Hold
2,601,517
0.12% 161
2013
Q2
$28.6M Buy
+2,601,517
New +$54.8M 0.11% 168

Other funds holding DVAX

Federated Hermes's DVAX Position: Q4 2025 in Review

Federated Hermes sold out of Dynavax Technologies (DVAX) in Q4 2025, closing a stake of 8,000 shares — an estimated $79.4K sold.

Federated Hermes first reported a position in DVAX in Q2 2013 and held it in 50 quarters. The position peaked at $295M in Q3 2021. 266 funds tracked by Wall St. Rank hold DVAX as of Q4 2025.

  • Federated Hermes reported no remaining Dynavax Technologies position as of Q4 2025 after selling out during the quarter.
  • Federated Hermes sold 8,000 Dynavax Technologies shares in Q4 2025, an estimated $79.4K.
  • Federated Hermes first reported a position in Dynavax Technologies in Q2 2013 and held it in 50 quarters.
  • Federated Hermes's Dynavax Technologies position peaked at $295M in Q3 2021.
  • 266 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2025.

Based on Federated Hermes's 13F filing for Q4 2025, filed 12 Feb 2026.